Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 841 AL 855

Targeting mitochondrial quality control in Alzheimer's disease: Mechanisms and therapeutic potential of phytomedicines

Lin Z, Zhang S, Sun M.

Pharmacol Res. 2026 Jun;228:108202. doi: 10.1016/j.phrs.2026.108202. Epub 2026 Apr 21.

Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery

Al Khzem AH, Gomaa MS.

Drug Des Devel Ther. 2026 Apr 13;20:597087. doi: 10.2147/DDDT.S597087. eCollection 2026.

From pathology to precision therapy: Contemporary and emerging strategies in Alzheimer's disease treatment

Belavadi S, Kadiri SK.

Eur J Pharmacol. 2026 May 28;1025:178913. doi: 10.1016/j.ejphar.2026.178913. Epub 2026 Apr 29.

Understanding the contribution of toxicant exposures to Alzheimer's disease and related dementias

Howell GR, Territo PR, Aylor D, Goldstein LE.

Curr Opin Neurobiol. 2026 Jun;98:103192. doi: 10.1016/j.conb.2026.103192. Epub 2026 Apr 9.

Neuropeptides in the Management of Alzheimer's Disease: From Pathophysiology to Therapeutic Opportunities

Tiwari S, Yadav SK, Kumari M, Dhakal T, Puranik N.

Int J Mol Sci. 2026 Apr 1;27(7):3206. doi: 10.3390/ijms27073206.

The interplay between mitophagy and ferroptosis in Alzheimer's disease: Mechanisms and therapeutic implications

Liu A, Xing L, Li J, Yao M, Song J, Guo W, Duan P, Li H.

J Alzheimers Dis. 2026 Apr;110(3):1022-1037. doi: 10.1177/13872877261420211. Epub 2026 Mar 13.

Epigenetics and the gut-brain axis: Insights into DNA methylation, aging, and Alzheimer disease

Kumar V, Shukla R, Gangani S, Joseph R, Jain S, Yadav H.

J Pharmacol Exp Ther. 2026 Apr;393(4):104299. doi: 10.1016/j.jpet.2026.104299. Epub 2026 Feb 12.

Lipid metabolic regulation of neuroinflammation in Alzheimer's disease

Li T, Guo K, Ma Y, Zhao J, Cao Y, Zhang R, Li X, Wei J, Ma Y, Zhu Z, Zhao D.

Front Immunol. 2026 May 12;17:1815719. doi: 10.3389/fimmu.2026.1815719. eCollection 2026.

Crosstalk between death-associated protein kinase 1-regulated mechanisms and dysfunctions in alzheimer's disease

Shukla S, Singh RK.

Mol Biol Rep. 2026 May 22;53(1):799. doi: 10.1007/s11033-026-11933-5.

The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET

Keshavan A, Wiltshire K, Wee R, Belio IG, Tucker K, Hart M, Lunn MP, David MCB, Rizzo L, Sadeghi-Alavijeh O, Wilson P, Gale DP, Heslegrave AJ, Zetterberg H, Fox NC, Malhotra P, Schott JM.

Alzheimers Dement. 2026 Feb;22(2):e71147. doi: 10.1002/alz.71147.

Inhaled General Anesthetics in Alzheimer's Disease Progression: Divergent Effects, Underlying Mechanisms, and Future Perspectives

Yang L, Song G, Parker E, Yang L.

Mol Neurobiol. 2026 Mar 31;63(1):542. doi: 10.1007/s12035-026-05832-w.

Unique Expression and Glycosylation of Amyloid Precursor Protein in Alzheimer's Disease

Tachida Y, Kitazume S.

Adv Exp Med Biol. 2026;1491:33-42. doi: 10.1007/978-3-032-04153-1_4.

Mechanistic Investigation of Exercise Interventions in Rodent Models of Alzheimer's Disease and Prospects for Clinical Translation

Peng T, Zhang Z, Ding N, Zhang J.

Neural Plast. 2026;2026(1):e6718671. doi: 10.1155/np/6718671.

Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease

Vijverberg EGB, Scharre DW, Woodward M, Catalano S, Hamby ME, Grundman M, Morgan RE, Iaci J, Devins T, Caggiano AO.

J Alzheimers Dis. 2026 May;111(2):897-908. doi: 10.1177/13872877261437145. Epub 2026 Apr 3.

Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence

Qi L, Zheng F, Tu M, Abdullah R, Zhao Y, Su X, Zhou D, Peng G.

J Prev Alzheimers Dis. 2026 Mar;13(3):100473. doi: 10.1016/j.tjpad.2025.100473. Epub 2026 Jan 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias